Dyadic Develops Stable C1 Cell Lines and Produces Purified Scripps-Designed Bundibugyo Ebola Antigens from Plasmids in Approximately 15 Days
Go back to Dyadic Develops Stable C1 Cell Lines and Produces Purified Scripps-Designed Bundibugyo Ebola Antigens from Plasmids in Approximately 15 Days| Dyadic International, Inc. (NASDAQ: DYAI) | Delayed: 0.40 -0.02 (4.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.42 | 52 Week High | $1.85 | |||
| Open | $0.40 | 52 Week Low | $1.32 | |||
| Day High | $0.43 | P/E | N/A | |||
| Day Low | $0.39 | EPS | $0.00 | |||
| Volume | 90,322 | |||||
